In 88 TGFBI highly expressed breast cancer patients, the percentage of ER + was 37.8 ± 4.4, while, in 48 TGFBI lowly expressed breast cancer patients, the percentage of ER + was 59.58 ± 5.8 (Fig. 4c). This evidence concerns the gene ESR1 and breast carcinoma.